Back to Search
Start Over
Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular Diseases.
- Source :
-
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2020 Feb; Vol. 34 (1), pp. 113-121. - Publication Year :
- 2020
-
Abstract
- Hydrogen sulfide (H <subscript>2</subscript> S), a novel gaseous signaling molecule, is a vital physiological signal in mammals. H <subscript>2</subscript> S protects the cardiovascular system via modulation of vasodilation, vascular remodeling, and inhibition of vascular calcification, and also has anti-atherosclerosis properties. Autophagy is a lysosomal-mediated intracellular degradation mechanism for excessive or abnormal proteins and lipids. The contribution of autophagy to normal and disease-state cell physiology is extremely complicated. Autophagy acts as a double-edged sword in the cardiovascular system. It can defend against damage to cells caused by environmental changes and it can also induce active cell death under certain conditions. In recent years, accumulating evidence indicates that H <subscript>2</subscript> S can up- or downregulate autophagy in many pathological processes, thereby switching from a harmful to a beneficial role. In this review, we summarize progress on understanding the mechanism by which H <subscript>2</subscript> S regulates autophagy in cardiovascular disease. We also discuss a H <subscript>2</subscript> S switch phenomenon that regulates autophagy and provides protection in cardiovascular diseases.
- Subjects :
- Animals
Apoptosis
Cardiovascular Agents therapeutic use
Cardiovascular Diseases drug therapy
Cardiovascular Diseases pathology
Cardiovascular Diseases physiopathology
Cardiovascular System drug effects
Cardiovascular System pathology
Cardiovascular System physiopathology
Humans
Hydrogen Sulfide therapeutic use
Signal Transduction
Autophagy drug effects
Cardiovascular Diseases metabolism
Cardiovascular System metabolism
Hydrogen Sulfide metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1573-7241
- Volume :
- 34
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Cardiovascular drugs and therapy
- Publication Type :
- Academic Journal
- Accession number :
- 32090295
- Full Text :
- https://doi.org/10.1007/s10557-019-06927-4